Article citationsMore >>

Lai T, Frugoli A, Barrows B, et al. Sevelamer Carbonate Crystal-Induced Colitis. Case reports in gastrointestinal medicine. 2020; 2020: 1-4.

has been cited by the following article:

Article

Sevelamer Induced Colitis Causing Deep Cratered Ulcer in an End-Stage Renal Disease Patient

1Albany Medical Center, Department of Internal Medicine, Albany, NY. USA

2Albany Medical Center, Department of Gastroenterology, Albany, NY. USA

3Albany Medical Center, Department of Pathology, Albany, NY. USA


American Journal of Medical Case Reports. 2022, Vol. 10 No. 6, 173-175
DOI: 10.12691/ajmcr-10-6-3
Copyright © 2022 Science and Education Publishing

Cite this paper:
Shawn Philip, Muhammad Farhan Ashraf, Mary Strader, Hala Abdelwahab, Asra Batool. Sevelamer Induced Colitis Causing Deep Cratered Ulcer in an End-Stage Renal Disease Patient. American Journal of Medical Case Reports. 2022; 10(6):173-175. doi: 10.12691/ajmcr-10-6-3.

Correspondence to: Shawn  Philip, Albany Medical Center, Department of Internal Medicine, Albany, NY. USA. Email: shawn.philip316@gmail.com

Abstract

Sevelamer is phosphate lowering oral agent used in chronic kidney disease (CKD) to decrease oral phosphate absorption. Sevelamer has been shown to cause crystalline induced colitis. This can manifest as abdominal pain or gastrointestinal bleeding. We present a case with chronic kidney disease and Moyamoya syndrome that presented with abdominal pain and anemia. Colonoscopy revealed a single circumferential cratered ulcer in the transverse colon. Pathology showed crystalline induced colitis. Sevelamer was discontinued and the patient`s symptoms improved.

Keywords